Can a daily pill slow cellular ageing? small study investigates
NCT ID NCT07659834
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a daily food supplement, taken for 30 days, can improve markers of cellular health in healthy adults aged 35 and over. The supplement contains ingredients thought to boost NAD+ levels and support energy production and antioxidant defenses. Researchers will measure changes in blood NAD+, other cellular markers, grip strength, and mood. The goal is to see if supplementation can support healthy ageing.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Longevity supplement (Niagen NR, trans resveratrol, niacin, CoQ10, copper)
- What this could lead to
- If the supplement boosts NAD+ levels and other cellular health markers, it could point toward a simple way to support healthy ageing.
- What could go wrong
- This is a very small, early study with only 18 participants and no placebo group, so results may not be reliable or generalizable. The supplement may have no meaningful effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Functional Gut Clinic
Manchester, M3 4BG, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new antibody tame the Body's allergic alarm system?
- Fingerprint sweat could replace oral swabs for drug testing
- Wearable tech puts hormone health to the test
- Can a single platform predict your risk for multiple chronic diseases?
- Can a better hazmat suit keep first responders safer and more effective?
- Home video tracking may expose the gap between clinic walking and real-world walking after stroke